129 related articles for article (PubMed ID: 19150063)
1. Omega-3 fatty acids improve postprandial lipaemia in patients with nephrotic range proteinuria.
Bell S; Cooney J; Packard CJ; Caslake M; Deighan CJ
Atherosclerosis; 2009 Jul; 205(1):296-301. PubMed ID: 19150063
[TBL] [Abstract][Full Text] [Related]
2. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
[TBL] [Abstract][Full Text] [Related]
3. ω-3 Fatty Acid Ethyl Esters Diminish Postprandial Lipemia in Familial Hypercholesterolemia.
Chan DC; Pang J; Barrett PH; Sullivan DR; Burnett JR; van Bockxmeer FM; Watts GF
J Clin Endocrinol Metab; 2016 Oct; 101(10):3732-3739. PubMed ID: 27490922
[TBL] [Abstract][Full Text] [Related]
4. The effect of omega-3 fatty acids on the atherogenic lipoprotein phenotype in patients with nephrotic range proteinuria.
Bell S; Cooney J; Packard CJ; Caslake MJ; Deighan CJ
Clin Nephrol; 2012 Jun; 77(6):445-53. PubMed ID: 22595386
[TBL] [Abstract][Full Text] [Related]
5. Postprandial lipaemia following consumption of a meal enriched with medium chain saturated and/or long chain omega-3 polyunsaturated fatty acids. A randomised cross-over study.
Austin G; Ferguson JJ; Thota RN; Singh H; Burrows T; Garg ML
Clin Nutr; 2021 Feb; 40(2):420-427. PubMed ID: 32684486
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 fatty acids improve postprandial lipemia and associated endothelial dysfunction in healthy individuals - a randomized cross-over trial.
Miyoshi T; Noda Y; Ohno Y; Sugiyama H; Oe H; Nakamura K; Kohno K; Ito H
Biomed Pharmacother; 2014 Oct; 68(8):1071-7. PubMed ID: 25458786
[TBL] [Abstract][Full Text] [Related]
7. Effects of increasing doses of simvastatin on fasting lipoprotein subfractions, and the effect of high-dose simvastatin on postprandial chylomicron remnant clearance in normotriglyceridemic patients with premature coronary sclerosis.
van Wijk JP; Buirma R; van Tol A; Halkes CJ; De Jaegere PP; Plokker HW; van der Helm YJ; Castro Cabezas M
Atherosclerosis; 2005 Jan; 178(1):147-55. PubMed ID: 15585212
[TBL] [Abstract][Full Text] [Related]
8. Test meals rich in marine long-chain n-3 polyunsaturated fatty acids increase postprandial chylomicron response.
Griffo E; Di Marino L; Patti L; Bozzetto L; Annuzzi G; Cipriano P; Mangione A; Della Pepa G; Cocozza S; Riccardi G; Rivellese AA
Nutr Res; 2014 Aug; 34(8):661-6. PubMed ID: 25193793
[TBL] [Abstract][Full Text] [Related]
9. Effect of ω-3 fatty acid ethyl esters on apolipoprotein B-48 kinetics in obese subjects on a weight-loss diet: a new tracer kinetic study in the postprandial state.
Wong AT; Chan DC; Barrett PH; Adams LA; Watts GF
J Clin Endocrinol Metab; 2014 Aug; 99(8):E1427-35. PubMed ID: 24606094
[TBL] [Abstract][Full Text] [Related]
10. Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, cross-over trial.
Hermansen K; Bækdal TA; Düring M; Pietraszek A; Mortensen LS; Jørgensen H; Flint A
Diabetes Obes Metab; 2013 Nov; 15(11):1040-8. PubMed ID: 23683069
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 fatty acid containing diets decrease plasma triglyceride concentrations in mice by reducing endogenous triglyceride synthesis and enhancing the blood clearance of triglyceride-rich particles.
Qi K; Fan C; Jiang J; Zhu H; Jiao H; Meng Q; Deckelbaum RJ
Clin Nutr; 2008 Jun; 27(3):424-30. PubMed ID: 18362042
[TBL] [Abstract][Full Text] [Related]
12. Exaggerated postprandial lipaemia and lower post-heparin lipoprotein lipase activity in middle-aged men.
Jackson KG; Knapper-Francis JM; Morgan LM; Webb DH; Zampelas A; Williams CM
Clin Sci (Lond); 2003 Oct; 105(4):457-66. PubMed ID: 12812518
[TBL] [Abstract][Full Text] [Related]
13. The contribution of splanchnic fat to VLDL triglyceride is greater in insulin-resistant than insulin-sensitive men and women: studies in the postprandial state.
Hodson L; Bickerton AS; McQuaid SE; Roberts R; Karpe F; Frayn KN; Fielding BA
Diabetes; 2007 Oct; 56(10):2433-41. PubMed ID: 17601988
[TBL] [Abstract][Full Text] [Related]
14. An acute intake of a walnut-enriched meal improves postprandial adiponectin response in healthy young adults.
Lozano A; Perez-Martinez P; Marin C; Tinahones FJ; Delgado-Lista J; Cruz-Teno C; Gomez-Luna P; Rodriguez-Cantalejo F; Perez-Jimenez F; Lopez-Miranda J
Nutr Res; 2013 Dec; 33(12):1012-8. PubMed ID: 24267040
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of CETP by torcetrapib attenuates the atherogenicity of postprandial TG-rich lipoproteins in type IIB hyperlipidemia.
Guerin M; Le Goff W; Duchene E; Julia Z; Nguyen T; Thuren T; Shear CL; Chapman MJ
Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):148-54. PubMed ID: 17951324
[TBL] [Abstract][Full Text] [Related]
16. Polyunsaturated fatty acids of the n-6 and n-3 series: effects on postprandial lipid and apolipoprotein levels in healthy men.
Zampelas A; Peel AS; Gould BJ; Wright J; Williams CM
Eur J Clin Nutr; 1994 Dec; 48(12):842-8. PubMed ID: 7889892
[TBL] [Abstract][Full Text] [Related]
17. Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes.
Bozzetto L; Annuzzi G; Corte GD; Patti L; Cipriano P; Mangione A; Riccardi G; Rivellese AA
Atherosclerosis; 2011 Jul; 217(1):142-8. PubMed ID: 21481394
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of postprandial hyperlipidaemia--remnants and coronary artery disease.
Karpe F
Diabet Med; 1997 Aug; 14 Suppl 3():S60-6. PubMed ID: 9272616
[TBL] [Abstract][Full Text] [Related]
19. Effect of orlistat on postprandial lipemia, NMR lipoprotein subclass profiles and particle size.
Suter PM; Marmier G; Veya-Linder C; Hänseler E; Lentz J; Vetter W; Otvos J
Atherosclerosis; 2005 May; 180(1):127-35. PubMed ID: 15823285
[TBL] [Abstract][Full Text] [Related]
20. Relationship between altered postprandial lipemia and insulin resistance in normolipidemic and normoglucose tolerant obese patients.
Guerci B; Vergès B; Durlach V; Hadjadj S; Drouin P; Paul JL
Int J Obes Relat Metab Disord; 2000 Apr; 24(4):468-78. PubMed ID: 10805504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
